Cargando…

Thyroid Hormones and Cardiometabolic Risk Factors in Saudi Women with Polycystic Ovary Syndrome: A Cross-Sectional Study

OBJECTIVE: The PCOS-thyroid nexus has recently drawn the focus of various investigations due to the prevalence of thyroid problems in PCOS. Additionally, risk factors for cardiovascular disease (CVD) are more prevalent in PCOS women. Therefore, we aim to assess the levels of thyroid hormones in Saud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saeed, Walaa Mohammed, Alsehli, Fahad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387246/ https://www.ncbi.nlm.nih.gov/pubmed/37525744 http://dx.doi.org/10.2147/IJWH.S405942

Ejemplares similares

Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018)

The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2020)

Polycystic Ovary Syndrome: Important Underrecognised Cardiometabolic Risk Factor in Reproductive-Age Women
por: Baldani, Dinka Pavicic, et al.
Publicado: (2015)

Correction to: The impact of atorvastatin on cardiometabolic risk factors in brothers of women with polycystic ovary syndrome
por: Krysiak, Robert, et al.
Publicado: (2021)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome
por: Çakır Biçer, Nihan, et al.
Publicado: (2023)

Low Vitamin D Level in Saudi Women With Polycystic Ovary Syndrome
por: Bindayel, Iman Abdullah
Publicado: (2021)

The role of the thyroid in polycystic ovary syndrome
por: Fan, Huanhuan, et al.
Publicado: (2023)

Hashimoto’s thyroiditis worsens ovaries in polycystic ovary syndrome patients compared to Anti-Müllerian hormone levels
por: Serin, Aliye Nigar, et al.
Publicado: (2021)

High Thyroid Stimulating Hormone Level Is Associated With Hyperandrogenism in Euthyroid Polycystic Ovary Syndrome (PCOS) Women, Independent of Age, BMI, and Thyroid Autoimmunity: A Cross-Sectional Analysis
por: Cai, Jie, et al.
Publicado: (2019)

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome
por: Deng, Yuying, et al.
Publicado: (2017)

Effects of Ketogenic Diet on Reproductive Hormones in Women With Polycystic Ovary Syndrome
por: Khalid, Karniza, et al.
Publicado: (2023)

Visceral Adiposity Index: Simple Tool for Assessing Cardiometabolic Risk in Women with Polycystic Ovary Syndrome
por: Agrawal, Hiya, et al.
Publicado: (2019)

Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
por: Torres Fernandez, Edgar D, et al.
Publicado: (2018)

Metabolic and Hormonal Profile of Adolescent Girls With Polycystic Ovary Syndrome With Concomitant Autoimmune Thyroiditis
por: Skrzyńska, Karolina Joanna, et al.
Publicado: (2021)

The Role of C-Peptide as Marker of Cardiometabolic Risk in Women With Polycystic Ovary Syndrome: A Controlled Study
por: de Medeiros, Sebastiao Freitas, et al.
Publicado: (2018)

Effect of soy phytoestrogen on metabolic and hormonal disturbance of women with polycystic ovary syndrome
por: Khani, Behnaz, et al.
Publicado: (2011)

Hormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits
por: de Melo, Anderson Sanches, et al.
Publicado: (2017)

A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
por: Shele, Grei, et al.
Publicado: (2020)

Body Composition and Its Impact on the Hormonal Disturbances in Women with Polycystic Ovary Syndrome
por: Bizoń, Anna, et al.
Publicado: (2021)

Anti-Müllerian Hormone and Polycystic Ovary Syndrome in Women and Its Male Equivalent
por: di Clemente, Nathalie, et al.
Publicado: (2022)

Assessment of the Role of the Anti-Mullerian Hormone, Luteinizing Hormone/Follicle Stimulating Hormone Ratio in the Diagnosis of Polycystic Ovary Syndrome in Sudanese Women
por: Tola, Hafza, et al.
Publicado: (2018)

Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin
por: Trouva, Anastasia, et al.
Publicado: (2022)

The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2021)

Adiponectin in Women with Polycystic Ovary Syndrome
por: Shin, Hyun-Young, et al.
Publicado: (2011)

Dyslipidemia in women with polycystic ovary syndrome
por: Kim, Jin Ju, et al.
Publicado: (2013)

Thyroid-stimulating Hormone and Insulin Resistance: Their Association with Polycystic Ovary Syndrome without Overt Hypothyroidism
por: Benetti-Pinto, Cristina Laguna, et al.
Publicado: (2017)

The Polycystic Ovary Syndrome: An update on metabolic and hormonal mechanisms
por: Dumitrescu, R, et al.
Publicado: (2015)

Thyroid disorders and polycystic ovary syndrome: An emerging relationship
por: Singla, Rajiv, et al.
Publicado: (2015)

Follicle-stimulating hormone receptor gene polymorphism in chronic anovulatory women, with or without polycystic ovary syndrome: a cross-sectional study
por: Singhasena, Wanakan, et al.
Publicado: (2014)

Association of Insulin Resistance with Lipid Profile, Metabolic Syndrome, and Hormonal Aberrations in Overweight or Obese Women with Polycystic Ovary Syndrome
por: Ebrahimi-Mamaghani, Mehranghiz, et al.
Publicado: (2015)

Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance
por: Jena, Sweekruti, et al.
Publicado: (2023)

Correlation of anti-Müllerian hormone levels with metabolic syndrome events in polycystic ovary syndrome: A cross-sectional study
por: Wiweko, Budi, et al.
Publicado: (2020)

rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women
por: Albalawi, Fadwa S., et al.
Publicado: (2018)

The Effect of Exercise on Cardiometabolic Risk Factors in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
por: Breyley-Smith, Annabelle, et al.
Publicado: (2022)

The Effective Factors on The Sexual Function of Polycystic Ovary Syndrome Women: A Cross-Sectional Study
por: Fereidooni, Bita, et al.
Publicado: (2022)

Study of Visceral and Subcutaneous Abdominal Fat Thickness and Its Correlation with Cardiometabolic Risk Factors and Hormonal Parameters in Polycystic Ovary Syndrome
por: Jena, Debarchan, et al.
Publicado: (2018)

Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013)

Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women
por: Yue, Chao-Yan, et al.
Publicado: (2018)

Hormonal and Metabolic Factors Influence the Action of Progesterone on the Endometrium of Women with Polycystic Ovary Syndrome
por: Baracat, Maria Candida P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6qvfd57kamseitp9mppavl3e8i